Liquidia Corp (LQDA)
13.00
+0.30
(+2.36%)
USD |
NASDAQ |
May 07, 12:31
Liquidia Max Drawdown (5Y): 93.87% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 93.87% |
March 31, 2024 | 93.87% |
February 29, 2024 | 93.87% |
January 31, 2024 | 93.87% |
December 31, 2023 | 93.87% |
November 30, 2023 | 93.87% |
October 31, 2023 | 93.87% |
September 30, 2023 | 93.87% |
August 31, 2023 | 93.87% |
July 31, 2023 | 93.87% |
June 30, 2023 | 93.87% |
May 31, 2023 | 93.87% |
April 30, 2023 | 93.87% |
March 31, 2023 | 93.87% |
February 28, 2023 | 93.87% |
January 31, 2023 | 93.87% |
December 31, 2022 | 93.87% |
November 30, 2022 | 93.87% |
October 31, 2022 | 93.87% |
September 30, 2022 | 93.87% |
August 31, 2022 | 93.87% |
July 31, 2022 | 93.87% |
June 30, 2022 | 93.87% |
May 31, 2022 | 93.87% |
April 30, 2022 | 93.87% |
Date | Value |
---|---|
March 31, 2022 | 93.87% |
February 28, 2022 | 93.87% |
January 31, 2022 | 93.87% |
December 31, 2021 | 93.87% |
November 30, 2021 | 93.87% |
October 31, 2021 | 93.87% |
September 30, 2021 | 93.87% |
August 31, 2021 | 93.87% |
July 31, 2021 | 93.81% |
June 30, 2021 | 93.49% |
May 31, 2021 | 93.49% |
April 30, 2021 | 93.49% |
March 31, 2021 | 93.49% |
February 28, 2021 | 93.01% |
January 31, 2021 | 93.01% |
December 31, 2020 | 93.01% |
November 30, 2020 | 92.50% |
October 31, 2020 | 92.31% |
September 30, 2020 | 91.74% |
August 31, 2020 | 91.74% |
July 31, 2020 | 91.74% |
June 30, 2020 | 91.74% |
May 31, 2020 | 91.74% |
April 30, 2020 | 91.74% |
March 31, 2020 | 91.74% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
78.03%
Minimum
May 2019
93.87%
Maximum
Aug 2021
92.44%
Average
93.87%
Median
Aug 2021
Max Drawdown (5Y) Benchmarks
United Therapeutics Corp | 60.30% |
AIM ImmunoTech Inc | 99.76% |
Perspective Therapeutics Inc | 91.70% |
Protalix BioTherapeutics Inc | 94.35% |
Armata Pharmaceuticals Inc | 99.87% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 1.479 |
Beta (5Y) | 0.2403 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 84.56% |
Historical Sharpe Ratio (5Y) | 0.0492 |
Historical Sortino (5Y) | 0.109 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 29.20% |